HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Combined therapy after superselective arterial cisplatin infusion to treat maxillary squamous cell carcinoma.

AbstractOBJECTIVE:
We sought to assess the efficacy of combined therapy after superselective arterial cisplatin infusion (SACI) therapy to treat the maxillary squamous cell carcinoma.
STUDY DESIGN:
We conducted a retrospective chart review of 50 patients. After completion of two courses of SACI, 25 of the patients were successively treated by concurrent SACI and radiotherapy (AR), while the other 25 patients were treated by surgery with postoperative radiotherapy (ASR).
RESULTS:
Patients with surgery (ASR) had an 88% local control rate with 75% disease-free survival rate at 60 months by Kaplan-Meier analysis, compared with 62% disease-free survival rate for patients with AR treatment. A particularly good outcome was obtained in T4 cases of the ASR group (n=8) whose 5-year survival rate was 87% and local control rate was 100%.
CONCLUSION/SIGNIFICANCE:
Combined SACI therapy is very effective for the treatment of maxillary squamous cell carcinomas and contributes to the improving prognoses of patients and organ preservation rates.
AuthorsKiyoto Shiga, Junkichi Yokoyama, Sho Hashimoto, Shigeru Saijo, Masaru Tateda, Takenori Ogawa, Mika Watanabe, Toshimitsu Kobayashi
JournalOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery (Otolaryngol Head Neck Surg) Vol. 136 Issue 6 Pg. 1003-9 (Jun 2007) ISSN: 0194-5998 [Print] England
PMID17547996 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cisplatin
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Carcinoma, Squamous Cell (drug therapy, pathology, radiotherapy, surgery)
  • Cisplatin (administration & dosage, adverse effects)
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Infusions, Intra-Arterial (methods)
  • Male
  • Maxilla (pathology, surgery)
  • Maxillary Sinus Neoplasms (drug therapy, pathology, radiotherapy, surgery)
  • Middle Aged
  • Neoplasm Staging
  • Orbit Evisceration

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: